YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
3.210
-0.660 (-17.05%)
Aug 28, 2026, 12:10 PM EDT - Market open
YD Bio Market Cap
YD Bio has a market cap or net worth of $225.73 million as of August 28, 2026. Its market cap has increased by 467.49% in one year.
Market Cap
225.73M
Enterprise Value
222.62M
1-Year Change
467.49%
Ranking
Category
Stock Price
$3.21
ChartMarket Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $225.73M, an increase of 52.15%. That is a compound annual growth rate of 7.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 225.73M | -73.67% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 282.20M |
| Neumora Therapeutics | 278.09M |
| Whitehawk Therapeutics | 277.63M |
| Pyxis Oncology | 276.91M |
| Greenwich LifeSciences | 274.92M |
| Sionna Therapeutics | 273.99M |
| Eledon Pharmaceuticals | 270.05M |
| AC Immune | 269.45M |